|
|
||||||||
Ann Thorac Surg 1997;64:1407-1408
© 1997 The Society of Thoracic Surgeons
Medical Research Council Cancer Trials Office 5 Shaftesbury Rd Cambridge CB2 2BW, United Kingdom
| The first 20% of the full text of this article appears below. |
See also page 1402.
Sawyer and associates rightly point out that the role of postoperative thoracic radiotherapy (TRT) in nonsmall cell lung cancer remains controversial. Their most valuable contribution has been to identify stage IIIA patients at high, intermediate, or low risk of local recurrence and of death. However, their conclusion that TRT is of benefit in patients with stage IIIA disease and high or
Related Article
Ann. Thorac. Surg. 1997 64: 1402-1407.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |